Method of Collection:
Volume as mentioned on gel vacutainer (Yellow)
Days for reporting:
Studies have shown that the Apo B : Apo A-1 Ratio distinguishes unequivocally bewteen persons with and those without CHD. Therefore,Apolipoprotein A-1 and B studies are superior to conventional Total Cholesterol, or HDL - & LDL - Cholesterol studies for predicting risk of Atherosclerosis. It is now proved in case studies that individuals with angiographically confirmed heart disease have significantly lower Apo A-1 and higher Apo B levels compared to normal persons.
Apolipoprotein studies have shown promise in improved management of patients of MI to reduce the risk of reinfarction. Monitoring of patients of Coronary Bypass Surgery with regard to risk and severity of restenosis is substantially better with these studies. On the preventive aspect, cases with family history of CHD show a higher degree of agreement with Apolipoprotein studies than with other lipid parameters. Genetic disorders of lipid metabolism can be recognised at a early stage and corrective measures taken,for example,in Familial Combined Hyperlipidaemia (responsible for >10% of MI~s) and Hyperapobetalipoproteinaemia (50% of all CHD patients).
Why is the Test Done?
This test is done for assessment of cardiovascular risk. Apo A1 is the major component of HDL and ApoB is the major component of LDL. levated ApoB and decreased ApoA1 are associated with increased risk of cardiovascular disease.
How to prepare for the Test:
No test preparation is needed